BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Nielsen AL, Strømgaard K. Recent achievements in developing selective G q inhibitors. Med Res Rev 2019;40:135-57. [DOI: 10.1002/med.21598] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Nubbemeyer B, Pepanian A, Paul George AA, Imhof D. Strategies towards Targeting Gαi/s Proteins: Scanning of Protein-Protein Interaction Sites To Overcome Inaccessibility. ChemMedChem 2021;16:1696-715. [PMID: 33615736 DOI: 10.1002/cmdc.202100039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li J, Ge Y, Huang JX, Strømgaard K, Zhang X, Xiong XF. Heterotrimeric G Proteins as Therapeutic Targets in Drug Discovery. J Med Chem 2020;63:5013-30. [PMID: 31841625 DOI: 10.1021/acs.jmedchem.9b01452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Hanke W, Patt J, Alenfelder J, Voss JH, Zdouc MM, Kehraus S, Kim JB, Grujičić GV, Namasivayam V, Reher R, Müller CE, Kostenis E, Crüsemann M, König GM. Feature-Based Molecular Networking for the Targeted Identification of Gq-Inhibiting FR900359 Derivatives. J Nat Prod 2021;84:1941-53. [PMID: 34197116 DOI: 10.1021/acs.jnatprod.1c00194] [Reference Citation Analysis]
4 Kuschak M, Schlegel JG, Schneider M, Kehraus S, Voss JH, Seidinger A, Matthey M, Wenzel D, Fleischmann BK, König GM, Müller CE. Sensitive LC-MS/MS Method for the Quantification of Macrocyclic Gαq Protein Inhibitors in Biological Samples. Front Chem 2020;8:833. [PMID: 33173765 DOI: 10.3389/fchem.2020.00833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang MW, Yang Z, Chen X, Zhou SH, Huang GL, Sun JN, Jiang H, Xu WM, Lin HC, Yu X, Sun JP. Activation of PTH1R alleviates epididymitis and orchitis through Gq and β-arrestin-1 pathways. Proc Natl Acad Sci U S A 2021;118:e2107363118. [PMID: 34740971 DOI: 10.1073/pnas.2107363118] [Reference Citation Analysis]
6 Küppers J, Benkel T, Annala S, Kimura K, Reinelt L, Fleischmann BK, Kostenis E, Gütschow M. Tetrahydroimidazo[1,2-a]pyrazine Derivatives: Synthesis and Evaluation as Gαq -Protein Ligands. Chemistry 2020;26:12615-23. [PMID: 32428383 DOI: 10.1002/chem.202001446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nakao K, Singh M, Sapkota K, Fitzgerald A, Hablitz JJ, Nakazawa K. 5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction. Transl Psychiatry 2022;12:168. [PMID: 35459266 DOI: 10.1038/s41398-022-01930-0] [Reference Citation Analysis]
8 Khalid E, Chang JP. Receptor-proximal effectors mediating GnRH actions in the goldfish pituitary: Involvement of G protein subunits and GRKs. General and Comparative Endocrinology 2022. [DOI: 10.1016/j.ygcen.2022.113991] [Reference Citation Analysis]
9 Schlegel JG, Tahoun M, Seidinger A, Voss JH, Kuschak M, Kehraus S, Schneider M, Matthey M, Fleischmann BK, König GM, Wenzel D, Müller CE. Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation? ACS Pharmacol Transl Sci 2021;4:888-97. [PMID: 33860209 DOI: 10.1021/acsptsci.1c00021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Voss JH, Nagel J, Rafehi M, Guixà-González R, Malfacini D, Patt J, Kehraus S, Inoue A, König GM, Kostenis E, Deupi X, Namasivayam V, Müller CE. Unraveling binding mechanism and kinetics of macrocyclic Gαq protein inhibitors. Pharmacol Res 2021;173:105880. [PMID: 34506902 DOI: 10.1016/j.phrs.2021.105880] [Reference Citation Analysis]
11 Hermes C, König GM, Crüsemann M. The chromodepsins - chemistry, biology and biosynthesis of a selective Gq inhibitor natural product family. Nat Prod Rep 2021. [PMID: 33998635 DOI: 10.1039/d1np00005e] [Reference Citation Analysis]
12 Hermes C, Richarz R, Wirtz DA, Patt J, Hanke W, Kehraus S, Voß JH, Küppers J, Ohbayashi T, Namasivayam V, Alenfelder J, Inoue A, Mergaert P, Gütschow M, Müller CE, Kostenis E, König GM, Crüsemann M. Thioesterase-mediated side chain transesterification generates potent Gq signaling inhibitor FR900359. Nat Commun 2021;12:144. [PMID: 33420046 DOI: 10.1038/s41467-020-20418-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
13 Ge Y, Shi S, Deng JJ, Chen XP, Song Z, Liu L, Lou L, Zhang X, Xiong XF. Design, Synthesis, and Evaluation of Small Molecule Gαq/11 Protein Inhibitors for the Treatment of Uveal Melanoma. J Med Chem 2021;64:3131-52. [PMID: 33715360 DOI: 10.1021/acs.jmedchem.0c01977] [Reference Citation Analysis]
14 Luo Y, Gou H, Chen X, Li L, Wang X, Xu Y. Lactate inhibits osteogenic differentiation of human periodontal ligament stem cells via autophagy through the MCT1-mTOR signaling pathway. Bone 2022;:116444. [PMID: 35589065 DOI: 10.1016/j.bone.2022.116444] [Reference Citation Analysis]
15 Lapadula D, Benovic JL. Targeting Oncogenic Gαq/11 in Uveal Melanoma. Cancers (Basel) 2021;13:6195. [PMID: 34944815 DOI: 10.3390/cancers13246195] [Reference Citation Analysis]
16 Rodgers RL. Glucagon, cyclic AMP, and hepatic glucose mobilization: A half‐century of uncertainty. Physiological Reports 2022;10. [DOI: 10.14814/phy2.15263] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]